Warsaw - Delayed Quote PLN
Captor Therapeutics Spolka Akcyjna (CTX.WA)
32.00
0.00
(0.00%)
At close: 4:41:19 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
19,356
13,201
9,158
3,986
--
Cost of Revenue
8,319
6,300
2,087
741
--
Gross Profit
11,037
6,901
7,071
3,245
--
Operating Expense
52,790
79,917
47,435
35,953
12,216
Operating Income
-41,753
-73,016
-40,364
-32,708
-12,216
Net Non Operating Interest Income Expense
947
2,760
2,548
-807
-393
Pretax Income
-41,152
-70,527
-35,894
-32,572
-12,694
Tax Provision
--
57
--
--
--
Net Income Common Stockholders
-41,152
-70,584
-35,894
-32,572
-12,694
Diluted NI Available to Com Stockholders
-41,152
-70,584
-35,894
-32,572
-12,694
Basic EPS
-7.50
-15.19
-8.61
-7.89
-3.91
Diluted EPS
-7.50
-15.19
-8.61
-789.00
-3.91
Basic Average Shares
4,989.36
4,645.71
4,168.13
4,127.97
3,248.17
Diluted Average Shares
5,122.14
4,769.53
4,357.32
4,356.58
3,256.47
Total Operating Income as Reported
-41,753
-73,016
-38,364
-31,709
-12,216
Total Expenses
61,109
86,217
49,522
36,694
12,216
Net Income from Continuing & Discontinued Operation
-41,152
-70,584
-35,894
-32,572
-12,694
Normalized Income
-41,152
-70,584
-37,894
-33,572
-12,694
Interest Income
1,333
3,083
3,127
--
--
Interest Expense
337
269
321
400
393
Net Interest Income
947
2,760
2,548
-807
-393
EBIT
-40,815
-70,258
-35,573
-32,172
-12,301
EBITDA
-35,743
-64,818
-28,479
-24,817
-5,699
Reconciled Cost of Revenue
8,319
6,300
2,087
741
--
Reconciled Depreciation
5,072
5,440
7,094
7,355
6,602
Net Income from Continuing Operation Net Minority Interest
-41,152
-70,584
-35,894
-32,572
-12,694
Total Unusual Items Excluding Goodwill
--
--
2,000
1,000
--
Total Unusual Items
--
--
2,000
1,000
--
Normalized EBITDA
-35,743
-64,818
-30,479
-25,817
-5,699
Tax Rate for Calcs
--
0
--
--
--
12/31/2020 - 4/20/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade